Clinical trial
Rosiglitazone Versus Placebo in Chronic Stable Angina
NCT00225355 · University of Glasgow, Other · Terminated
Key facts
| NCT number | NCT00225355 |
|---|---|
| Title | Rosiglitazone Versus Placebo in Chronic Stable Angina |
| Official title | Insulin Sensitisation as a Novel Mechanism to Lessen Ischaemic Burden in Overweight Non-Diabetic Patients With Chronic Stable Angina: A Pilot Study |
| Lead sponsor | University of Glasgow, Other |
| Collaborators | British Heart Foundation GlaxoSmithKline Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Angina Pectoris, Metabolic Syndrome X |
| Intervention type | Drug |
| Interventions | Rosiglitazone |
| Enrollment | 80 |
| Start date | Feb 1, 2006 |
| Completion | Nov 1, 2006 |
| First posted | Sep 23, 2005 |
| Last update posted | Feb 19, 2009 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: